Clinical Trial: A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Dry Eye Disease
Study Type: INTERVENTIONAL
Official Title: A Phase 3b Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes
Brief Summary:
The purpose of this study is to evaluate the proportion of ocular adverse events reported in subjects with dry eye disease (DED) between the intervention arm (0.003% AR-15512) and Refresh® Classic.
Read more